Industry News
Global Kinetics to present at philanthropic forum
Melbourne's Global Kinetics will present details of the company and its Parkinson's Kinetograph symptom-monitoring device at a global philanthropic forum in New York in May.
[ + ]Patrys produces IgM antibodies using plants
Patrys (ASX:PAB) has published data on a study involving using a plant-based production system to produce IgM antibodies such as the company's anticancer candidate PAT-SM6. [ + ]
A new funding program to support biopharmaceutical manufacturing development
The first round of a new pilot funding program opens this week in Queensland, with at least $2 million available for biopharmaceutical product developers wanting to make use of BioPharmaceuticals Australia's (BPA) new mammalian cell contract manufacturing facility, operated by DSM Biologics (DSMB). [ + ]
Patrys antibody produced in plants
The IgM antibody PAT-SM6, developed by biotechnology company Patrys, has been produced through a plant-based manufacturing system. [ + ]
Chocolate slime at ANSTO this Easter
The Australian Nuclear Science and Technology Organisation (ANSTO), located in Sydney's Sutherland Shire, is once again holding its Easter school science workshops. [ + ]
Botox may smooth out depression
Researchers have conducted the largest randomised, double-blind, placebo-controlled study to date on the effect of OnabotulinumtoxinA (OBA, or Botox) on depression. [ + ]
Time to rework the funding cycle?
Preparing grant proposals for a single annual deadline is stressful, time-consuming and conflicts with personal responsibilities, a study confirms. [ + ]
Antisense MS candidate well tolerated in monkeys
Antisense Therapeutics' (ASX:ANP) in-licensed MS drug candidate ATL1102 was found to be well tolerated at two dose levels during a long-term animal trial. [ + ]
Prana shares sink after Alzheimer's trial disappoints
Shares in Prana Biotechnology (ASX:PBT) fell 73% after the company revealed that a phase II trial of PBT2 in Alzheimer's disease did not meet its primary and some secondary endpoints. [ + ]
E. coli strain nears complete resistance
Genome sequencing of a multidrug-resistant Escherichia coli strain has revealed this bacterium is close to becoming resistant to almost all antibiotics. [ + ]
E. coli strain close to complete resistance
An international study, led by The University of Queensland (UQ), has been tracking a multidrug-resistant E. coli strain that is only one gene away from being resistant to almost all antibiotics. [ + ]
EKF acquires STI
EKF Diagnostics, a global in vitro diagnostics business, has acquired Separation Technology Inc (STI), a Florida-based manufacturer of in vitro diagnostics devices for haematology testing. [ + ]
Fast-paced evolution of proteins
Researchers have uncovered a new family of seed proteins as well as provided an explanation for 'de novo protein evolution'. [ + ]
FANTOM adds an atlas of human gene expression to the DNA library
The international research consortium FANTOM (Functional Annotation of the Mammalian Genome) has released the first comprehensive map of gene activity across the human body and provided the first holistic view of the complex networks that regulate gene expression across the cell types that make up a human being. [ + ]
Simon McKeon to give National Press Club Address
AusBiotech has welcomed news that Simon McKeon AO will speak at the National Press Club in Canberra about the Strategic Review of Health and Medical Research in Australia. [ + ]
